Integrin-linked kinase (ILK): the known vs. the unknown and perspectives
Open Access
- 28 January 2022
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (2) , 1-26
Abstract
Integrin-linked kinase (ILK) is a multifunctional molecular actor in cell–matrix interactions, cell adhesion, and anchorage-dependent cell growth. It combines functions of a signal transductor and a scaffold protein through its interaction with integrins, then facilitating further protein recruitment within the ILK–PINCH–Parvin complex. ILK is involved in crucial cellular processes including proliferation, survival, differentiation, migration, invasion, and angiogenesis, which reflects on systemic changes in the kidney, heart, muscle, skin, and vascular system, also during the embryonal development. Dysfunction of ILK underlies the pathogenesis of various diseases, including the pro-oncogenic activity in tumorigenesis. ILK localizes mostly to the cell membrane and remains an important component of focal adhesion. We do know much about ILK but a lot still remains either uncovered or unclear. Although it was initially classified as a serine/threonine-protein kinase, its catalytical activity is now questioned due to structural and functional issues, leaving the exact molecular mechanism of signal transduction by ILK unsolved. While it is known that the three isoforms of ILK vary in length, the presence of crucial domains, and modification sites, most of the research tends to focus on the main isoform of this protein while the issue of functional differences of ILK2 and ILK3 still awaits clarification. The activity of ILK is regulated on the transcriptional, protein, and post-transcriptional levels. The crucial role of phosphorylation and ubiquitylation has been investigated, but the functions of the vast majority of modifications are still unknown. In the light of all those open issues, here we present an extensive literature survey covering a wide spectrum of latest findings as well as a past-to-present view on controversies regarding ILK, finishing with pointing out some open questions to be resolved by further research.Keywords
Funding Information
- Narodowe Centrum Nauki (2016/22/E/NZ3/00654, 2019/35/O/NZ3/02328)
This publication has 249 references indexed in Scilit:
- Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancerJournal of Molecular Histology, 2012
- Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of CaveolaeDevelopmental Cell, 2010
- The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!The EMBO Journal, 2009
- The Pseudoactive Site of ILK Is Essential for Its Binding to α-Parvin and Localization to Focal AdhesionsMolecular Cell, 2009
- The structural basis of integrin-linked kinase–PINCH interactionsProceedings of the National Academy of Sciences, 2008
- Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinaseProceedings of the National Academy of Sciences, 2007
- Integrin-linked kinase: a cancer therapeutic target unique among its ILKNature Reviews Cancer, 2005
- Complete sequencing and characterization of 21,243 full-length human cDNAsNature Genetics, 2003
- Anoikis mechanismsCurrent Opinion in Cell Biology, 2001
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997